"These data from the BREAKWATER study show the potential for this targeted treatment regimen to become the new standard of care for people with BRAF V600E-mutant metastatic colorectal cancer ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

SAN FRANCISCO – Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a ...

肝内胆管癌（intrahepatic cholangiocarcinoma, ICC）是一种高度异质性的肿瘤，分子分型是实施ICC 个体化治疗的基础。正确的检测方法对于全面筛选适用靶向药物的患者群体具有重要的临床意义。本共识基于国内外临床实践数据，结合国情，围绕ICC重要靶点进行制定，提出了15 条推荐意见，以期为ICC ...

Aromatase inhibitors (AIs) are becoming the hormonal treatment of choice for postmenopausal women with early breast cancer. Large, well-controlled clinical studies have established the efficacy ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The case will be revisited on January 27. Earlier on Monday, the Islamabad High Court (IHC) had issued notices to jail authorities in response to a petition filed by Pakistan Tehreek-e-Insaf (PTI ...